Last checked at 10 Jun 2021 12:34
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 09 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,877,144 | 1.46% | 230,795 | 0.18% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 94,581 | 0.07% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,955,603 | 1.52% | 331,476 | 0.26% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 13 | 254.5700 USD |
Purchase | 20 | 253.1800 USD |
Purchase | 100 | 253.4900 USD |
Purchase | 100 | 253.4200 USD |
Purchase | 100 | 253.1940 USD |
Purchase | 154 | 254.4165 USD |
Purchase | 180 | 253.8983 USD |
Purchase | 200 | 253.6200 USD |
Purchase | 200 | 253.6500 USD |
Purchase | 200 | 253.6950 USD |
Purchase | 234 | 253.7775 USD |
Purchase | 267 | 253.7314 USD |
Purchase | 289 | 253.7167 USD |
Purchase | 300 | 253.5000 USD |
Purchase | 308 | 254.9775 USD |
Purchase | 367 | 253.8022 USD |
Purchase | 600 | 253.6300 USD |
Purchase | 600 | 253.7000 USD |
Purchase | 672 | 253.8391 USD |
Purchase | 936 | 253.8801 USD |
Purchase | 2,800 | 254.2737 USD |
Purchase | 3,449 | 254.1284 USD |
Purchase | 3,715 | 254.5099 USD |
Purchase | 4,109 | 254.7792 USD |
Purchase | 4,532 | 254.0140 USD |
Purchase | 4,966 | 253.7199 USD |
Purchase | 9,076 | 254.5100 USD |
Purchase | 10,733 | 253.9705 USD |
Purchase | 23,133 | 254.1759 USD |
Purchase | 30,000 | 253.6619 USD |
Sale | 89 | 253.5300 USD |
Sale | 100 | 253.7900 USD |
Sale | 100 | 255.2200 USD |
Sale | 117 | 254.5379 USD |
Sale | 154 | 254.4165 USD |
Sale | 207 | 254.3511 USD |
Sale | 210 | 253.2266 USD |
Sale | 369 | 253.7478 USD |
Sale | 580 | 254.7339 USD |
Sale | 830 | 253.9381 USD |
Sale | 887 | 253.7851 USD |
Sale | 1,030 | 253.5308 USD |
Sale | 1,071 | 253.8155 USD |
Sale | 1,101 | 253.8176 USD |
Sale | 1,877 | 253.7237 USD |
Sale | 2,746 | 254.5100 USD |
Sale | 3,578 | 254.3137 USD |
Sale | 3,715 | 254.5099 USD |
Sale | 3,952 | 253.9084 USD |
Sale | 4,010 | 254.8302 USD |
Sale | 4,521 | 254.0230 USD |
Sale | 9,509 | 253.6519 USD |
Sale | 9,752 | 254.2001 USD |
Sale | 12,164 | 253.7462 USD |
Sale | 18,200 | 253.8599 USD |
Sale | 21,167 | 254.1259 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 10 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005509/en/
Copyright Business Wire 2021